Neutrophil activating peptide 2 or analog thereof is administered to a mammal to achieve {TAIL ~ therapeutic reduction} of {HEAD ~ the number} of circulating platelets 
Neutrophil activating peptide 2 or analog thereof is administered to a mammal to achieve { TAIL ~ therapeutic reduction } of { HEAD ~ the number } of circulating platelets
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL OTH HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH